Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Gains from Investment Securities (2016 - 2024)

Historic Gains from Investment Securities for Sunshine Biopharma (SBFM) over the last 5 years, with Q4 2024 value amounting to -$373529.0.

  • Sunshine Biopharma's Gains from Investment Securities changed N/A to -$373529.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$373529.0, marking a year-over-year decrease of 13907.16%. This contributed to the annual value of $582483.0 for FY2024, which is N/A changed from last year.
  • Per Sunshine Biopharma's latest filing, its Gains from Investment Securities stood at -$373529.0 for Q4 2024.
  • Sunshine Biopharma's Gains from Investment Securities' 5-year high stood at $956012.0 during Q1 2024, with a 5-year trough of -$373529.0 in Q4 2024.